These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22052313)

  • 1. Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.
    Zimber MP; Ziering C; Zeigler F; Hubka M; Mansbridge JN; Baumgartner M; Hubka K; Kellar R; Perez-Meza D; Sadick N; Naughton GK
    J Drugs Dermatol; 2011 Nov; 10(11):1308-12. PubMed ID: 22052313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
    Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
    J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A; Iorizzo M; Botta GL; Milani M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study.
    Kapoor R; Shome D
    J Cosmet Laser Ther; 2018 Oct; 20(6):369-379. PubMed ID: 29482481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial.
    Oura H; Iino M; Nakazawa Y; Tajima M; Ideta R; Nakaya Y; Arase S; Kishimoto J
    J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials.
    Lindenbaum ES; Feitelberg AL; Tendler M; Beach D; Gamliel-Lazarovich A; Har-Shai Y; Hirshowitz B
    Dermatol Online J; 2003 Feb; 9(1):4. PubMed ID: 12639462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study.
    Pumthong G; Asawanonda P; Varothai S; Jariyasethavong V; Triwongwaranat D; Suthipinittharm P; Ingkaninan K; Leelapornpisit P; Waranuch N
    J Dermatolog Treat; 2012 Oct; 23(5):385-92. PubMed ID: 21756154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH; Menefee E; Sanchez M; Kaufman KD
    J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD; Girman CJ; Round EM; Johnson-Levonas AO; Shah AK; Rotonda J
    Eur J Dermatol; 2008; 18(4):407-11. PubMed ID: 18573713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
    Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
    Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing.
    Heier JS; Boyer D; Nguyen QD; Marcus D; Roth DB; Yancopoulos G; Stahl N; Ingerman A; Vitti R; Berliner AJ; Yang K; Brown DM;
    Ophthalmology; 2011 Jun; 118(6):1098-106. PubMed ID: 21640258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dutasteride improves male pattern hair loss in a randomized study in identical twins.
    Stough D
    J Cosmet Dermatol; 2007 Mar; 6(1):9-13. PubMed ID: 17348989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of efficacy of polysorbate 60 in the treatment of male pattern baldness.
    Groveman HD; Ganiats T; Klauber MR
    Arch Intern Med; 1985 Aug; 145(8):1454-8. PubMed ID: 3896179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.
    Eun HC; Kwon OS; Yeon JH; Shin HS; Kim BY; Ro BI; Cho HK; Sim WY; Lew BL; Lee WS; Park HY; Hong SP; Ji JH
    J Am Acad Dermatol; 2010 Aug; 63(2):252-8. PubMed ID: 20605255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
    DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
    Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-month, randomized, double-blind, placebo-controlled study evaluating the ability of a marine complex supplement to promote hair growth in men with thinning hair.
    Ablon G
    J Cosmet Dermatol; 2016 Dec; 15(4):358-366. PubMed ID: 27506633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.